Rice University nanomedicine co. to begin generating commercial revenue

//Rice University nanomedicine co. to begin generating commercial revenue

Rice University nanomedicine co. to begin generating commercial revenue

Two commercial partners of Houston-based biotech firm Nanospectra Biosciences Inc. plan to launch consumer products in the U.S. in 2019, according to an Oct. 30 release from the company. Having previously been funded only by private equity investments and grant money, the two products will provide Nanospectra with its first source of commercial revenue since the biotech company was founded in 2001. David Jorden, CEO of Nanospectra Biosciences, said that the revenue from the commercial products…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2018-11-03T16:19:03+00:00 November 3rd, 2018|Healthcare|

About the Author: